You just read:

BioLineRx Announces Initiation of Triple Combination Arm of Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer Under Immuno-Oncology Collaboration

News provided by

BioLineRx Ltd

Dec 11, 2018, 07:00 ET